NCT00384176 2017-04-14
HORIZON III
AstraZeneca
Phase 2/3 Completed
Clinical Trials
5 trialsNCT00588900 2017-04-05
Irinotecan and Cediranib in Treating Patients With Metastatic Colorectal Cancer That Did Not Respond to Previous Oxaliplatin, Fluoropyrimidine, and Bevacizumab
Alliance for Clinical Trials in Oncology
Phase 2 Terminated
NCT00399035 2016-12-28
HORIZON II
AstraZeneca
Phase 3 Completed
NCT00494221 2014-03-27
A Phase I/II Study of Cediranib (AZD2171) in Japanese Metastatic Colorectal Cancer Patients in Combination With FOLFOX
AstraZeneca
Phase 1/2 Completed
NCT00278889 2012-10-24
HORIZON I
AstraZeneca
Phase 2 Completed